Help Us Better Understand the Effects of Praluent® in Pregnancy
Many women need to take medication during pregnancy to appropriately manage a chronic health condition. In some cases, avoiding or stopping medication use during pregnancy may be more harmful than taking medication. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where you come in!
MotherToBaby is currently enrolling pregnant women in a study examining the use of Praluent® (alirocumab) to treat primary hypercholesterolemia and atherosclerotic cardiovascular disease (ASCVD), or primary hypercholesterolemia associated with familial hypercholesterolemia (FH) during pregnancy.
Are you currently pregnant? Did you take Praluent® at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about Praluent® use in pregnancy.
“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”
Christina Chambers, PhD, MPH
UC San Diego Center for Better Beginnings
Lead Investigator, MotherToBaby Pregnancy Studies
Will you take the step and become our partner? Make an impact on the health of future moms and babies today by joining our Praluent® & Pregnancy Study!